Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Using an inducible knockout model of the tumor-suppressive isoform of hepatocyte nuclear factor 4 alpha ("P1-HNF4α") in the liver in combination with prolonged high fat (HF) diet, we found that HCC developed equally in male and female mice as early as 38 weeks of age.
|
31575546 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
HNF‑4α downregulation promotes tumor migration and invasion by regulating E‑cadherin in renal cell carcinoma.
|
31322246 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Clinically, HIC1 and HNF4A conversely correlate with tumor stage in liver cancer.
|
31108460 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These data demonstrate that HNF4α does not play a major role during β-catenin-driven HCC, thus revealing that the tumour suppressor role of HNF4α is far more complex and dependent probably on its temporal expression and tumour context.
|
30721564 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
It also regulated crucial transcription factors viz. hepatocyte nuclear factor alpha (HNF4A) and tumor suppressor protein 53 (p53).
|
30414976 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We reveal mechanisms underlying the incompatibility of BMAL1 and P2-HNF4α in HCC, and demonstrate that forced expression of BMAL1 in HNF4α-positive HCC prevents the growth of tumors in vivo.
|
30341289 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Of these factors, HNF4A acts both as a master regulator of liver organogenesis and a tumor suppressor in the liver.
|
29899848 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Additionally, immunohistochemistry demonstrated that HNF-4α was overexpressed in human GC tissues, and associated with tumor stage and lymph node metastasis.
|
29344114 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In normal cells, E-cadherin exerts its tumour suppressing role mainly by sequestering β-catenin from its binding to LEF (Lymphoid enhancer factor)/TCF (T cell factor) which serves the function of transcribing genes of the proliferative Wnt signaling pathway.
|
29279096 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The protein expression of the tumor suppressor HNF4α may be inhibited by interactions of RBPs with the G4 motif in the 5' UTR to promote cell proliferation during liver development and carcinogenesis.
|
29234104 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The study also identified MYC, HNF4A and TGFB1 as top upstream regulators correlating to tumor tissue content.
|
28445515 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We identified a group of CTNNB1/TCF target genes that are activated in the absence of TCF7L1, including EPHB3, a marker of Paneth cell differentiation that has also been implicated as a tumor suppressor in CRC.
|
27333864 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Multiple sets of genes and molecular biological processes involved during HCC development were identified from this integrative analysis: (i) Loss of liver cellular features due to the reduced HNF4A & PPAR signaling in the early stages of HCC, (ii) activated inflammatory and stress signals in the cirrhosis stages and (iii) highly activated cellular proliferation with the activated E2F-MYC oncogenic signaling with the gain of embryonic liver stem cell-like features in the advanced stage tumors.
|
27194100 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Additionally, nude mice administered MSC-HNF4α exhibited significantly smaller tumors compared with controls in vivo.
|
27124543 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Collectively, our data indicate that TCF-4K functions as a tumor suppressor in NSCLC by down-regulating the Wnt pathway.
|
26535715 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
To investigate whether this discrepancy is due to different HNF4α isoforms derived from its two promoters (P1 and P2), we generated Tet-On-inducible human colon cancer (HCT116) cell lines that express either the P1-driven (HNF4α2) or P2-driven (HNF4α8) isoform and analyzed them for tumor growth and global changes in gene expression (transcriptome sequencing [RNA-seq] and chromatin immunoprecipitation sequencing [ChIP-seq]).
|
26240283 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
This inhibition of proliferation was associated with a decrease in cyclin D1 levels, orchestrated principally by HNF-4α, a target of miR-34a considered to act as a tumour suppressor in the liver.
|
25792709 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Stable DKK4-transfected cells were established, and DKK4 functional analyses were performed, including a T-cell factor/lymphoid enhancer factor (TCF/LEF) reporter assay, and experiments on cell viability, apoptosis, invasive capability and tumor growth in vivo.
|
24573574 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The expression of E-cadherin, Fibronectin, N-cadherin, Vimentin, Hepatocyte nuclear factor 4alpha (HNF4alpha), Snail and Slug was assessed in primary tumors and their corresponding metastases by immunohistochemical staining.
|
24059685 |
2013 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
These cellular results were confirmed using tumor xenografts in mice, as DSG3 silencing led to the suppressed tumor growth, plakoglobin translocation and reduced expression of TCF/LEF target genes in tumors.
|
23737966 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5.
|
23435428 |
2014 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemical analysis of approximately 450 human colon cancer specimens (Stage III) reveals that P1-HNF4α is either lost or localized in the cytoplasm in approximately 80% of tumors, and that staining for active Src correlates with those events in a subset of samples.
|
22308320 |
2012 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Here, we show that Hnf4α does not act as a tumor-suppressor gene but is crucial in promoting gut tumorigenesis in mice.
|
21062980 |
2010 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
High TCF activity Huh7 cells led to earlier and larger tumor formation when xenografted into nude mice.
|
20538055 |
2010 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In contrast, P2-HNF4alpha was expressed in all tumors regardless of the mucin phenotype.
|
19563409 |
2009 |